ACRV   $8.26  4.96% Market Closed After Close 8.25 -0.12%

Acrivon Therapeutics Inc
Total Cash 180.54M
totalCashPerShare 5.829
EBITDA -75.56M
Total Debt 4.22M
quickRatio 15.999
currentRatio 16.161
Total Revenue
debtToEquity 1.954
Revenue/Share
ROA -0.24414
ROE -0.37784
grossProfits
freeCashflow -31.31M
operatingCashflow -53.16M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 63.72M
forwardPE -2.8703704
floatShares 11.23M
sharesOutstanding 30.97M
sharesShort 1.21M
sharesShortPriorMonth 1.03M
dateShortInterest
sharesPercentSharesOut 0.04%
heldPercentInsiders 0.22%
heldPercentInstitutions 0.76%
Short Ratio help_outline 8.73%
shortPercentOfFloat 0.10%
impliedSharesOutstanding
bookValue 6.977
Price To Book help_outline 1.11
earningsQuarterlyGrowth
netIncomeToCommon -69.00M
trailingEps -2.72%
forwardEps -2.70%
enterpriseToEbitda -0.84
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.58 3Q 2024
institutionsCount 81
lastUpdated Oct. 17, 2024, 9:49 a.m.